State Street Corp Dynavax Technologies Corp Transaction History

State Street Corp

$2.36 Trillion
Q1 2025

A detailed history of State Street Corp transactions in Dynavax Technologies Corp stock. As of the latest transaction made, State Street Corp holds 6,790,463 shares of DVAX stock, worth $69.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,790,463

Previous 7,794,524 12.88%

Holding current value

$69.8 Million

Previous $99.5 Million 11.52%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$12.39 - $14.4 $12.4 Million - $14.5 Million	-1,004,061 Reduced 12.88%	6,790,463 $88.1 Million
Q4 2024 Feb 14, 2025	BUY	$10.28 - $13.66 $1.07 Million - $1.42 Million	104,250 Added 1.36%	7,794,524 $99.5 Million
Q3 2024 Nov 14, 2024	SELL	$10.05 - $11.61 $2.74 Million - $3.16 Million	-272,501 Reduced 3.42%	7,690,274 $85.7 Million
Q2 2024 Aug 14, 2024	SELL	$10.73 - $12.58 $28.4 Million - $33.3 Million	-2,648,966 Reduced 24.96%	7,962,775 $89.4 Million
Q1 2024 May 15, 2024	BUY	$11.7 - $14.98 $13.1 Million - $16.7 Million	1,115,956 Added 11.75%	10,611,741 $132 Million
Q4 2023 Feb 14, 2024	BUY	$13.09 - $14.98 $16.2 Million - $18.6 Million	1,239,597 Added 15.01%	9,495,785 $133 Million
Q3 2023 Nov 14, 2023	BUY	$12.64 - $14.99 $5.91 Million - $7.01 Million	467,821 Added 6.01%	8,256,188 $122 Million
Q2 2023 Aug 14, 2023	SELL	$9.85 - $13.17 $11.4 Million - $15.2 Million	-1,155,281 Reduced 12.92%	7,788,367 $101 Million
Q1 2023 May 15, 2023	SELL	$9.44 - $11.88 $9.9 Million - $12.5 Million	-1,048,856 Reduced 10.5%	8,943,648 $87.7 Million
Q4 2022 Feb 14, 2023	SELL	$10.27 - $13.29 $2.89 Million - $3.74 Million	-281,726 Reduced 2.74%	9,992,504 $106 Million
Q3 2022 Nov 15, 2022	BUY	$9.93 - $17.44 $16.3 Million - $28.7 Million	1,644,803 Added 19.06%	10,274,230 $107 Million
Q2 2022 Aug 15, 2022	BUY	$7.45 - $12.83 $973,677 - $1.68 Million	130,695 Added 1.54%	8,629,427 $109 Million
Q1 2022 May 16, 2022	BUY	$9.75 - $14.44 $22 Million - $32.5 Million	2,253,376 Added 36.08%	8,498,732 $92.1 Million
Q4 2021 Feb 14, 2022	BUY	$13.17 - $20.94 $13.6 Million - $21.6 Million	1,031,099 Added 19.77%	6,245,356 $87.9 Million
Q3 2021 Nov 15, 2021	SELL	$9.16 - $19.83 $16.5 Million - $35.6 Million	-1,796,822 Reduced 25.63%	5,214,257 $100 Million
Q2 2021 Aug 16, 2021	SELL	$7.25 - $10.99 $526,966 - $798,808	-72,685 Reduced 1.03%	7,011,079 $69.1 Million
Q1 2021 May 17, 2021	SELL	$4.57 - $11.18 $17.4 Million - $42.5 Million	-3,803,532 Reduced 34.94%	7,083,764 $69.6 Million
Q4 2020 Feb 16, 2021	SELL	$3.73 - $5.6 $2.67 Million - $4.01 Million	-715,811 Reduced 6.17%	10,887,296 $48.4 Million
Q3 2020 Nov 10, 2020	BUY	$4.32 - $11.7 $28.3 Million - $76.6 Million	6,544,323 Added 129.37%	11,603,107 $50.1 Million
Q2 2020 Aug 14, 2020	BUY	$2.94 - $9.1 $4.82 Million - $14.9 Million	1,640,072 Added 47.97%	5,058,784 $44.9 Million
Q1 2020 May 11, 2020	BUY	$2.27 - $6.2 $7.76 Million - $21.2 Million	3,418,712 New	3,418,712 $12.1 Million

Others Institutions Holding DVAX

# of Institutions

311

Shares Held

129M

Call Options Held

493K

Put Options Held

269K

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.3B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Dynavax Technologies Corp Transaction History